Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I study of E7010.
Yamamoto K, Noda K, Yoshimura A, Fukuoka M, Furuse K, Niitani H. Yamamoto K, et al. Among authors: furuse k. Cancer Chemother Pharmacol. 1998;42(2):127-34. doi: 10.1007/s002800050795. Cancer Chemother Pharmacol. 1998. PMID: 9654112 Clinical Trial.
[LY188011 phase I study. Research Group of Gemcitabine (LY188011)].
Taguchi T, Furuse K, Fukuoka M, Shimoyama T, Morimoto K, Nakamura T, Furue H, Majima H, Niitani H, Ohta K, Wakui A, Nakao I, Tsukagoshi S. Taguchi T, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 1996 Jul;23(8):1011-8. Gan To Kagaku Ryoho. 1996. PMID: 8687215 Clinical Trial. Japanese.
Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients. SDZ ILE 964 (IL-3) Study.
Kudoh S, Sawa T, Kurihara N, Furuse K, Kurita Y, Fukuoka M, Takada M, Takaku F, Ogawa M, Ariyoshi Y. Kudoh S, et al. Among authors: furuse k. Cancer Chemother Pharmacol. 1996;38 Suppl:S89-95. doi: 10.1007/s002800051046. Cancer Chemother Pharmacol. 1996. PMID: 8765425 Clinical Trial.
[Phase I study of raltitrexed (ZD-1694)].
Horikoshi N, Aiba K, Fukuoka M, Akazawa S, Sakata Y, Furuse K, Kanamaru R, Kudoh S, Konishi T, Kurihara M, Niitani H, Furue H, Tsukagoshi S, Taguchi T, Yoshida S, Ota K, Kotake T, Wakui A. Horikoshi N, et al. Among authors: furuse k. Gan To Kagaku Ryoho. 1998 Nov;25(13):2075-84. Gan To Kagaku Ryoho. 1998. PMID: 9838910 Clinical Trial. Japanese.
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.
Takada M, Fukuoka M, Ariyoshi Y, Furuse K, Niitani H, Ota K, Motomiya M, Hasegawa K, Tominaga K, Kuriyama T, et al. Takada M, et al. Among authors: furuse k. Cancer Chemother Pharmacol. 1992;31(3):182-6. doi: 10.1007/BF00685545. Cancer Chemother Pharmacol. 1992. PMID: 1281446 Clinical Trial.
258 results